# Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer

> **NCT00818350** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Campania Younger Oncologists Association** · enrollment: 25 (actual)

## Conditions studied

- Urinary Bladder Neoplasms

## Interventions

- **DRUG:** SUNITINIB

## Key facts

- **NCT ID:** NCT00818350
- **Lead sponsor:** Campania Younger Oncologists Association
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2009-08
- **Final completion:** 2011-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2009-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00818350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00818350, "Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00818350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*